UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Macquarie Group Ltd.

Macquarie Group Ltd. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,660,567 shares of the healthcare conglomerate’s stock after acquiring an additional 106,527 shares during the quarter. UnitedHealth Group makes up about 0.9% of Macquarie Group Ltd.’s holdings, making the stock its 6th biggest holding. Macquarie Group Ltd.’s holdings in UnitedHealth Group were worth $784,651,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Moneta Group Investment Advisors LLC grew its position in UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares in the last quarter. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter valued at $5,210,004,000. Gateway Advisory LLC lifted its holdings in shares of UnitedHealth Group by 48,406.9% during the 1st quarter. Gateway Advisory LLC now owns 4,762,407 shares of the healthcare conglomerate’s stock valued at $4,762,000 after buying an additional 4,752,589 shares during the last quarter. Envestnet Asset Management Inc. raised its position in UnitedHealth Group by 264.2% during the first quarter. Envestnet Asset Management Inc. now owns 5,511,174 shares of the healthcare conglomerate’s stock valued at $732,934,000 after acquiring an additional 3,997,959 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares in the last quarter. Hedge funds and other institutional investors own 85.69% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, CEO Andrew Witty sold 4,000 shares of the business’s stock in a transaction dated Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the sale, the chief executive officer now directly owns 78,573 shares in the company, valued at $39,772,866.87. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.35% of the stock is owned by insiders.

UnitedHealth Group Stock Down 0.0 %

Shares of NYSE:UNH opened at $479.84 on Thursday. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $558.10. The stock has a market cap of $444.48 billion, a price-to-earnings ratio of 21.47, a P/E/G ratio of 1.43 and a beta of 0.66. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80. The company has a 50 day moving average of $491.09 and a 200-day moving average of $486.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, beating analysts’ consensus estimates of $5.92 by $0.22. The business had revenue of $92.90 billion during the quarter, compared to the consensus estimate of $90.97 billion. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The firm’s revenue was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.57 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 24.83 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date is Friday, September 8th. UnitedHealth Group’s dividend payout ratio is currently 33.65%.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. HSBC began coverage on shares of UnitedHealth Group in a research report on Wednesday, September 6th. They set a “hold” rating and a $540.00 target price on the stock. StockNews.com began coverage on shares of UnitedHealth Group in a research note on Thursday, August 17th. They issued a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft decreased their price target on shares of UnitedHealth Group from $564.00 to $555.00 in a report on Monday, July 17th. Truist Financial lowered their target price on UnitedHealth Group from $610.00 to $580.00 in a report on Wednesday, June 14th. Finally, UBS Group raised their price objective on shares of UnitedHealth Group from $510.00 to $520.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 19th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $575.65.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.